Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-08-09 Purchase | 2023-08-09 6:57 pm | Xeris Biopharma Holdings Inc. | XERS | Edick Paul R See Remarks | 10,000 | $2.3794 | $23,794 | 2,321,494 (Indirect Direct) | View |
| 2022-12-13 Purchase | 2022-12-14 4:11 pm | Xeris Biopharma Holdings Inc. | XERS | Edick Paul R See Remarks | 20,000 | $1.45 | $29,000 | 1,561,494 (Indirect Direct) | View |
| 2022-05-12 Purchase | 2022-05-13 4:19 pm | Xeris Biopharma Holdings Inc. | XERS | Edick Paul R See Remarks | 100,000 | $1.4038 | $140,380 | 1,541,494 (Indirect Direct) | View |
| 2021-11-15 Purchase | 2021-11-16 4:25 pm | Xeris Biopharma Holdings Inc. | XERS | Edick Paul R See Remarks | 20,000 | $2.2832 | $45,664 | 841,494 (Indirect Direct) | View |
| 2021-11-11 Purchase | 2021-11-12 5:09 pm | Xeris Biopharma Holdings Inc. | XERS | Edick Paul R See Remarks | 200,000 | $2.0788 | $415,760 | 821,494 (Indirect Direct) | View |
| 2020-12-09 Purchase | 2020-12-10 4:52 pm | XERIS PHARMACEUTICALS INC | XERS | Edick Paul R See Remarks | 10,000 | $4.0551 | $40,551 | 424,564 (Indirect Direct) | View |
| 2020-05-08 Purchase | 2020-05-11 5:06 pm | XERIS PHARMACEUTICALS INC | XERS | Edick Paul R See Remarks | 33,000 | $3 | $99,000 | 414,564 (Indirect Direct) | View |
| 2020-02-14 Purchase | 2020-02-18 5:02 pm | XERIS PHARMACEUTICALS INC | XERS | Edick Paul R See Remarks | 20,000 | $4.15 | $83,000 | 196,564 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-01-31 Option Award | 2024-01-31 5:04 pm | N/A 2026-03-03 | Xeris Biopharma Holdings Inc. | XERS | Edick Paul R See Remarks | 2,000,000 | $0 | 4,321,494 (Direct) | View |
| 2023-01-31 Option Award | 2023-02-01 4:13 pm | N/A N/A | Xeris Biopharma Holdings Inc. | XERS | Edick Paul R See Remarks | 750,000 | $0 | 2,311,494 (Direct) | View |
| 2022-01-03 Option Award | 2022-01-05 6:16 pm | N/A N/A | Xeris Biopharma Holdings Inc. | XERS | Edick Paul R See Remarks | 600,000 | $0 | 1,441,494 (Direct) | View |
| 2021-10-05 Option Award | 2021-10-05 7:49 pm | N/A 2027-01-27 | Xeris Biopharma Holdings Inc. | XERS | Edick Paul R See Remarks | 2,057,633 | $0 | 2,057,633 (Direct) | View |
| 2021-10-05 Disposition | 2021-10-05 5:36 pm | N/A 2027-01-27 | XERIS PHARMACEUTICALS INC | XERS | Edick Paul R Chief Executive Officer | 2,057,633 | $0 | 0 (Direct) | View |
| 2021-01-29 Option Award | 2021-02-01 4:22 pm | N/A 2031-01-29 | XERIS PHARMACEUTICALS INC | XERS | Edick Paul R See Remarks | 625,000 | $0 | 1,049,564 (Direct) | View |
| 2020-06-05 Option Award | 2020-06-08 7:00 pm | N/A 2030-06-05 | Milestone Pharmaceuticals Inc. | MIST | Edick Paul R Director | 15,000 | $0 | 15,000 (Direct) | View |
| 2020-01-31 Option Award | 2020-03-02 4:52 pm | N/A N/A | XERIS PHARMACEUTICALS INC | XERS | Edick Paul R See Remarks | 185,000 | $0 | 381,564 (Direct) | View |
| 2020-01-31 Tax Withholding | 2020-02-04 5:00 pm | N/A N/A | XERIS PHARMACEUTICALS INC | XERS | Edick Paul R See Remarks | 9,801 | $6.37 | 176,564 (Direct) | View |